EFung Capital logo

EFung Capital

Asia, Guangdong, China, Shenzhen

Description

Shenzhen EFUNG Investment Management Enterprise is an institution that invests in professional biomedical industries.

Investor Profile

EFung Capital has made 8 investments, with 1 in the past 12 months and 25% as lead.

Stage Focus

  • Series A (63%)
  • Series Unknown (25%)
  • Angel (13%)

Country Focus

  • China (63%)
  • United States (25%)
  • India (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Battery
  • Electric Vehicle
  • Financial Services
  • Fintech
  • Oncology
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does EFung Capital frequently co-invest with?

Hyde Capital
North America, California, United States, Santa Monica
Co-Investments: 1
China Capital Management
Asia, Beijing, China, Beijing
Co-Investments: 1
RI
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Alteria Capital
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
Avaana Capital
Asia, Maharashtra, India, Mumbai
Co-Investments: 1
V
North America, California, United States, San Mateo
Co-Investments: 2
HT Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Panacea Venture
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 2
Tigermed
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1

Which angels does EFung Capital often collaborate with?

Shared Deals: 1

What are some of recent deals done by EFung Capital?

Suzhou Meichuang

Suzhou Shi, Jiangsu, China

Meichuang focuses on the innovative R&D, manufacturing and commercialization of high-end medical devices.

MedicalMedical Device
Series AJan 15, 2025
Amount Raised: $13,640,518
Turno

Bengaluru, Karnataka, India

Turno is an automobile company that provides 3 wheeled electric vehicles and financing to customers.

BatteryElectric VehicleFinancial ServicesFinTech
Series AFeb 9, 2023
Amount Raised: $13,570,535
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series UnknownSep 27, 2021
Amount Raised: $60,000,000
3D Medicines

Minhang, Shanghai, China

3D Medicines mission is to improve people’s health through cancer personalized diagnostics and treatment.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownOct 9, 2020
Amount Raised: $140,000,000
TriArm Therapeutics

Beijing, Beijing, China

TriArm Therapeutics is a developer of cellular immunotherapy products intended for the treatment of cancer patients.

BiotechnologyHealth Care
Series AJul 19, 2019
Amount Raised: $20,000,000
Tactiva Therapeutics

Buffalo, New York, United States

Tactiva Therapeutics is a development stage immuno-oncology company

BiotechnologyOncology
Series ADec 3, 2018
Amount Raised: $35,000,000
KBP Biosciences

Princeton, New Jersey, United States

A multinational clinical stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series AJan 5, 2018
Amount Raised: $76,000,000
UNIHZ TECHNOLOGY

Shenzhen, Guangdong, China

UNIHZ TECHNOLOGY provides intelligent transportation products and solutions.

Information TechnologyService IndustryTransportation
AngelJul 25, 2012
Amount Raised: $469,583